Cr. Bjarkam et al., New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders, BIOGERONTOL, 2(3), 2001, pp. 193-207
Neurodegenerative diseases are often considered incurable with no efficient
therapies to modify or halt the progress of disease, and ultimately lead t
o reduced quality of life and to death. Our knowledge of the nervous system
in health and disease has, however, increased considerably during the last
fifty years and today, neuroscience reveals promising new strategies to de
al with disorders of the nervous system. Some of these results have been im
plemented with success in the treatment of Parkinson's disease, a common ne
urodegenerative illness affecting approximately 1% of the population aged s
eventy or more. Parkinson's disease is characterized by a massive loss of d
opaminergic neurons in the substantia nigra, leading to severe functional d
isturbance of the neuronal circuitry in the basal ganglia. A thorough descr
iption of basal ganglia circuitry in health and disease is presented. We de
scribe how the functional disturbances seen in Parkinson's disease may be c
orrected at specific sites in this circuitry by medical treatment or, in ad
vanced stages of Parkinson's disease, by neurosurgical methods. The latter
include lesional surgery, neural transplantation and deep brain stimulation
, together with future treatment strategies using direct or indirect implan
tation of genetically modified cell-lines capable of secreting neurotrophic
factors or neurotransmitters. Advantages and disadvantages are briefly men
tioned for each strategy and the implications for the future and the possib
le use of these interventions in other neurodegenerative diseases are discu
ssed, with special emphasis on deep brain stimulation.